The University of Washington School of Pharmacy’s Drug Interaction Database has been awarded the Gary Neil Prize for Innovation in Drug Development from the American Society for Clinical Pharmacology & Therapeutics. Built with the goal of helping to prevent health complications from adverse drug reactions, one of the leading causes of injury and death in health care settings, the database has operated for more than 20 years.
“The award from the American Society for Clinical Pharmacology & Therapeutics is a great acknowledgement of the impact we’ve had in the drug development space…We built something from scratch at the University of Washington, and now it is internationally recognized as an authoritative research tool, with over 180 organizations from 40 different countries as subscriber,” said Dr. Isabelle Ragueneau-Majlessi, DIDB co-founder and director of Drug Interaction Solutions.